Biotech Manufacturing Companies in Delaware

Delaware has approximately 650 manufacturing establishments and 28,000 manufacturing employees. Delaware has a concentrated chemical and pharmaceutical manufacturing sector, historically anchored by DuPont and a network of specialty chemical producers.

Delaware contributes to the national biotech manufacturing landscape. Biotech manufacturing encompasses the production of biologic drugs including monoclonal antibodies, cell and gene therapies, vaccines, and recombinant proteins. Unlike traditional pharmaceutical manufacturing, biotech production relies on living cell systems and requires specialized bioprocessing equipment, single-use systems, and advanced purification technologies.

Monoclonal Antibody Producers: Companies operating large-scale mammalian cell culture facilities for antibody drug production.

Cell Therapy Manufacturers: Facilities producing autologous and allogeneic cell therapies including CAR-T and stem cell products.

Gene Therapy Producers: Companies manufacturing viral vectors (AAV, lentivirus) for gene therapy applications.

Vaccine Manufacturers: Facilities producing vaccines using traditional and mRNA platforms, including fill-finish operations.

Contract Biologics Manufacturers: CDMOs specializing in biologic drug manufacturing, from cell line development through commercial production.

Major industrial centers in Delaware include Wilmington, Dover, and Newark. These cities have concentrations of manufacturers across sectors including chemical manufacturing, pharmaceutical manufacturing, and food processing manufacturing.